Sortilin, carbamylation, and cardiovascular calcification in chronic kidney disease

Archive ouverte

Massy, Ziad A. | Liabeuf, Sophie

Edité par CCSD ; Nature Publishing Group -

International audience. Sortilin appears to play important roles in the pathogenesis of vascular and metabolic diseases, such as cardiovascular calcification. Post-translational modifications of sortilin (i.e., phosphorylation or carbamylation) are among the key mechanisms of its actions. Recent data extended the role of carbamylated sortilin to the pathogenesis of cardiovascular calcifications in chronic kidney disease. Whether therapeutic tools potentially available to inhibit the carbamylation process in chronic kidney disease patients would allow preventing cardiovascular calcifications remains to be demonstrated. Copyright (C) 2021, International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Consulter en ligne

Suggestions

Du même auteur

Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney Disease

Archive ouverte | Massy, Ziad A. | CCSD

International audience. In patients with chronic kidney disease (CKD), uremic toxins constitute a specific non-traditional risk factor. Research in this field started in the early 1990s, and a growing body of precli...

From old uraemic toxins to new uraemic toxins: place of `omics'

Archive ouverte | Massy, Ziad A. | CCSD

International audience. Uraemic toxins seem to play an important role in the genesis of cardiovascular and renal damage in chronic kidney disease patients. This short article is divided into two thematic sections. T...

Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?

Archive ouverte | Liabeuf, Sophie | CCSD

International audience. Chronic kidney disease (CKD) has emerged as a global public health problem. Although the incidence and prevalence of CKD vary from one country to another, the estimated worldwide prevalence i...

Chargement des enrichissements...